For the quarter ending 2025-09-30, VYCO had -$35,470 decrease in cash & cash equivalents over the period. -$72,428 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | 4,936 | -14,676 |
| Depreciation of fixed assets | 15,868 | 31,131 |
| Allowance for doubtful accounts - accounts receivable | 2,690 | 0 |
| Stock based compensation | 12,209 | 36,629 |
| Accounts receivable | 126,074 | -42,591 |
| Inventory | -6,568 | 8,304 |
| Prepaid expenses | 19,993 | 10,614 |
| Accrued interest - related party | -2,429 | 25,142 |
| Accrued interest | 12,098 | 23,803 |
| Accounts payable | -17,221 | -37,527 |
| Accrued liabilities | 38,868 | -68,726 |
| Changes in discontinued operations, net | 53 | 275 |
| Cash (used in) provided by operating activities | -72,427 | 19,724 |
| Purchase of fixed assets | 1 | 3,618 |
| Sale of fixed assets | 1 | 841 |
| Cash used in investing activities | 0 | -2,777 |
| Proceeds - notes payable other | 59,024 | 0 |
| Repayments - notes payable other | 22,067 | 22,895 |
| Cash provided by financing activities | 36,957 | -22,895 |
| Effect of exchange rate changes on cash | - | 0 |
| Net (decrease) increase in cash | -35,470 | -5,948 |
| Cash and cash equivalents at beginning of period | 105,648 | - |
| Cash and cash equivalents at end of period | 64,230 | - |
VYCOR MEDICAL INC (VYCO)
VYCOR MEDICAL INC (VYCO)